Who Are We?

TLS Healthcare Partners (“TLS”) is a consortium of independent investors who seek opportunities in the healthcare industry. Through TLS, members gain broader access to investment opportunities while entrepreneurs benefit from the deep operating and financial experience of TLS members.

The TLS Difference

TLS is a unique source of capital for healthcare entrepreneurs and business operators. We are not a venture capital or private equity fund but a consortium of accredited investors. We work together to identify value-generating investment opportunities. By using the group’s collective industry experience and network, deal flow is increased, and potential transactions are reviewed with more confidence.

For entrepreneurs, TLS adds value beyond providing a source of capital.  Members add value to the businesses that they invest in by leveraging their extensive network, industry knowledge and operational expertise to assist management teams with business, financial and product/company strategies.

TLS focuses on early stage and lower middle market transactions – both revenue generating and start-up businesses. Transactions range in value from $500,000 to $30 million. We seek investments in the following types of businesses:

• Branded and generic pharmaceutical drugs
• Medical devices
• Diagnostic tests and equipment
• Healthcare data technology
• Software as medical device (saMD) products

TLS offers members and entrepreneurs a unique approach to early stage and lower middle market healthcare opportunities, an investment segment where there currently exist few options for efficient access.